Cargando…

Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study

BACKGROUND: Patients with risk factors or established atherosclerotic cardiovascular disease remain at high‐risk for ischemic events. Triglyceride levels may play a causal role. METHODS AND RESULTS: We performed a retrospective study of adults aged ≥45 years receiving statin therapy, with a low‐dens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrosy, Andrew P., Yang, Jingrong, Sung, Sue Hee, Allen, Amanda R., Fitzpatrick, Jesse K., Rana, Jamal S., Wagner, Jeffrey, Philip, Sephy, Abrahamson, David, Granowitz, Craig, Go, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751901/ https://www.ncbi.nlm.nih.gov/pubmed/34622663 http://dx.doi.org/10.1161/JAHA.120.020377

Ejemplares similares

Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study
por: Wagner, Jeffrey R., et al.
Publicado: (2022)

Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin‐controlled LDL cholesterol
por: Nichols, Gregory A., et al.
Publicado: (2018)

Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins
por: Leatherman, Sarah, et al.
Publicado: (2022)

Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated Patients
por: Toth, Peter P, et al.
Publicado: (2019)

High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
por: Toth, Peter P., et al.
Publicado: (2018)

Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007–2014
por: Fan, Wenjun, et al.
Publicado: (2020)

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study
por: Ballantyne, Christie M., et al.
Publicado: (2019)

Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021)

Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014
por: Fan, Wenjun, et al.
Publicado: (2020)

Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014
por: Fan, Wenjun, et al.
Publicado: (2019)

Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high‐risk statin‐treated patients: A large administrative retrospective analysis
por: Toth, Peter P., et al.
Publicado: (2019)

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
por: Toth, Peter P., et al.
Publicado: (2019)

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
por: Taskinen, Marja-Riitta, et al.
Publicado: (2023)

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis
por: Brinton, Eliot A., et al.
Publicado: (2018)

Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)
por: Ambrosy, Andrew P., et al.
Publicado: (2021)

Dialogue: Vitamin D, statins and atherosclerotic progression in paediatric lupus
por: Gilkeson, Gary, et al.
Publicado: (2015)

Genetic Variations, Triglycerides, and Atherosclerotic Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study
por: Fitzpatrick, Jesse K, et al.
Publicado: (2022)

Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
por: d'Anglemont de Tassigny, Xavier, et al.
Publicado: (2017)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Controlling the thickness of the atherosclerotic plaque by statin medication
por: Formanowicz, Dorota, et al.
Publicado: (2020)

Obituary – Dr. KP Srivastava
por: Pruthi, KK
Publicado: (2017)

Correction: Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2018)

Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
por: Reiner, Željko
Publicado: (2018)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Characterization of Klebsiella pneumoniae bacteriophages, KP1 and KP12, with deep learning-based structure prediction
por: Kim, Youngju, et al.
Publicado: (2023)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Obituary: Prof. K.P. Thomas
por: Nandakumar, U.R.
Publicado: (2020)

Recombinase-Aided Amplification Assay for Rapid Detection of Hypervirulent Klebsiella pneumoniae (hvKp) and Characterization of the hvKp Pathotype
por: Yan, Chao, et al.
Publicado: (2023)

Residual risks and evolving atherosclerotic plaques
por: Noothi, Sunil K., et al.
Publicado: (2023)

D-particles, Matrix Integrals and KP hierachy
por: Kazakov, Vladimir A., et al.
Publicado: (1998)

An elementary approach to the rational solutions of the KP hierarchy
por: Falqui, G, et al.
Publicado: (1998)

Model independent calculation of Kp dispersion relations
por: López, C, et al.
Publicado: (1972)

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
por: Tada, Hayato, et al.
Publicado: (2018)

Association between the Triglyceride-Glucose Index and the Risk of Large Artery Atherosclerotic Stroke
por: Jiang, Mingfei, et al.
Publicado: (2022)

A dispersion relation investigation of high-energy Kp forward scattering amplitudes and of Kp asymptopia using recent cross-section data
por: Meyer, W, et al.
Publicado: (1972)

Comparative genomic analysis of Klebsiella pneumonia (LCT-KP214) and a mutant strain (LCT-KP289) obtained after spaceflight
por: Guo, Yinghua, et al.
Publicado: (2014)

Distribution of Kell antigens K, k, Kp(a), and Kp(b) among blood donors in Jeddah city of Western Saudi Arabia
por: Felimban, Raed I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i14ln38anljdre8vnokcvp6984